THU0404 INFLUENCE OF URATE TRANSPORTOSOME FOR HYPERURICEMIA AND GOUT
Blanka Stibůrková(Charles University), Karel Pavelká(Institute of Rheumatology), Jakub Závada(Institute of Rheumatology), Tappei Takada(University of Tokyo Hospital), Markéta Pavlı́ková(Charles University), Lenka Hasíková(Charles University), Kateřina Pavelcová(Institute of Rheumatology), Jana Bohatá(Institute of Rheumatology), Yu Toyoda(University of Tokyo Hospital)
Cited by 1
Related Papers
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
|The Lancet|2004|1.8k
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis
|Annals of the Rheumatic Diseases|2013|1.4k
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
|Annals of the Rheumatic Diseases|2011|988
Decreased extra-renal urate excretion is a common cause of hyperuricemia
|Nature Communications|2012|703
Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population
|Science Translational Medicine|2009|438